Paradigm Biocapital Advisors’s Immunovant IMVT Stock Holding History

Paradigm Biocapital Advisors’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell
2024 Q3	$38.9M	Hold
2024 Q2	$36M	Buy
2024 Q1	$25.8M	Buy